Luckys Pharma Lab Private Limited

Introduction

Depagin M 10/1000mg Tablet is a combination medication used in the management of type 2 diabetes mellitus. It aids in controlling elevated blood sugar levels associated with diabetes, thereby reducing the risk of serious complications and preventing heart disease.

Uses

Depagin M 10/1000mg Tablet is indicated for the treatment of type 2 diabetes mellitus.

Benefits

Depagin M 10/1000mg Tablet helps regulate high blood glucose levels by facilitating the removal of excess glucose from the body through urine. Lowering blood glucose levels is crucial for managing diabetes and reducing the risk of associated complications such as kidney damage, eye damage, nerve problems, and limb loss. Additionally, this medication reduces the risk of cardiovascular disease-related mortality in individuals with type 2 diabetes who already have cardiovascular disease. When taken regularly along with a proper diet and exercise regimen, it supports a normal, healthy life. Continuation of treatment as prescribed is essential for safeguarding future health.

Roset 20 Tablet belongs to a group of medicines called statins. It is used to lower cholesterol and reduce the risk of heart disease. Cholesterol is a fatty substance that builds up in your blood vessels and causes narrowing, which may lead to a heart attack or stroke.

Roset 20 Tablet is a widely prescribed medicine and is regarded as safe for long-term use. It can be taken with a meal or on an empty stomach. You can take it at any time of the day but try to take it at the same time each day. Most people with high cholesterol do not feel ill, but stopping your medicine may increase your cholesterol levels, making your condition worse and increasing your risk of heart disease and stroke.

It is important to have your cholesterol levels checked regularly. This medicine is only one part of the treatment program which should also include a healthy diet, regular exercise, smoking cessation, moderation of alcohol intake, and weight reduction. You can eat normally while taking this medicine, but try to avoid foods that are high in fat.

Key Features

• Dual-action formula for comprehensive symptom relief in asthma and COPD.
• Precision-engineered rotacap design for convenient and accurate dosing.
• Long-lasting efficacy with gradual onset of action for sustained therapeutic benefit.
• Suitable for long-term use, promoting symptom control and improved lung function.
• Emphasizes the importance of correct inhaler technique for enhanced drug efficacy.

INTRODUCTION OF lEVOICE A2

Levoice - A2 Tablet is used to treat and prevent asthma and symptoms of chronic obstructive pulmonary disorder such as coughing, wheezing and shortness of breath. It helps relax the muscles of the air passage thereby making it easier to breathe.

Levoice - A2 tablet is taken with or without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicines. You should keep taking these medicines for as long as your doctor 

recommends. If you stop treatment too early your symptoms may come back and your conditions may worsen.

USES

 Treatment of chronic obstructive pulmonary disease (copd)

 
BENEFITS

 Levoice - A2 tablet is a combination of two medicines that helps the airways in your lungs stay open. They work by relaxing the muscles of their airways. This makes it easier of air to get in and out. This medicines also loosens thick mucus, making it easier to cough out. It will relieve symptoms such as tightness in your chest, shortness of breath, wheezing and coughing and help you carry out your daily activities more easily. This medicine is safe and effective. It usually starts to work within few minutes and the effects can last up to several hours. Take it as prescribed by the doctor. Do not stop using it unless you are advised to by your doctor.

BUDEFLO 200: Dual Therapy for Effective Respiratory Management

BUDEFLO 200 combines Budesonide I.P. 200 mcg and Formoterol Fumarate Dihydrate I.P. 6 mcg, offering a powerful dual-action approach to manage asthma and chronic obstructive pulmonary disease (COPD). Budesonide, a potent inhaled corticosteroid (ICS), reduces airway inflammation, prevents swelling, and minimizes the risk of exacerbations. Formoterol Fumarate, a long-acting beta-agonist (LABA), ensures rapid and sustained bronchodilation, providing quick relief from breathing difficulties and improving airflow.

BUDEFLO 400 Keyhaler: Advanced Dual Therapy for Severe Respiratory Conditions

BUDEFLO 400 Keyhaler is a powerful combination of Budesonide I.P. 400 mcg and Formoterol Fumarate Dihydrate I.P. 6 mcg, specifically designed for the effective management of asthma and severe chronic obstructive pulmonary disease (COPD). Budesonide, a high-dose inhaled corticosteroid (ICS), reduces airway inflammation, prevents swelling, and lowers the risk of exacerbations. Formoterol Fumarate, a long-acting beta-agonist (LABA), delivers rapid and sustained bronchodilation, ensuring quick relief from bronchospasms and improved airflow. 

Glimiford, marketed by Luckys Pharma Lab Pvt. Ltd., is a clinically trusted oral anti-diabetic formulation that combines Glimepiride and Metformin Hydrochloride to provide effective glycemic control in patients with Type 2 Diabetes Mellitus. Glimepiride, a sulfonylurea, works by stimulating insulin secretion from the pancreas, while Metformin, a biguanide, reduces hepatic glucose production and enhances peripheral insulin sensitivity. This dual-action therapy addresses both insulin deficiency and resistance, helping manage both fasting and postprandial blood glucose levels. Glimiford is well-tolerated, does not cause significant weight gain, and offers a convenient and cost-effective solution for long-term diabetes management. It is available in multiple strengths to suit individual patient needs, and is backed by the trusted quality and commitment of Luckys Pharma Lab Pvt. Ltd.

Levoice A2 contains Acebrophylline 100 mg and Acetylcysteine 600 mg, a combination used primarily in the management of respiratory conditions like chronic obstructive pulmonary disease (COPD) and bronchial asthma.

• Acebrophylline 100 mg: A bronchodilator with mucolytic and anti-inflammatory properties. It helps in relaxing the smooth muscles of the airways, reducing inflammation, and promoting mucus clearance, thus improving breathing.

• Acetylcysteine 600 mg: A mucolytic agent that breaks down thick mucus, making it easier to expel. It helps in reducing the viscosity of secretions, which facilitates better lung function and helps in alleviating symptoms like cough and congestion.

TROPIUM-LS Keyhaler: Dual Bronchodilator Therapy for Respiratory Relief

TROPIUM-LS Keyhaler combines Ipratropium Bromide 40 mcg and Levosalbutamol 100 mcg to provide effective relief from bronchospasms associated with asthma, chronic obstructive pulmonary disease (COPD), and other obstructive airway disorders. Ipratropium Bromide, a short-acting muscarinic antagonist (SAMA), works by relaxing airway muscles and reducing bronchial secretions, promoting better airflow. Levosalbutamol, a short-acting beta-agonist (SABA), provides rapid bronchodilation, relieving acute breathing difficulties and reducing airway resistance.

BUDEFLO 200: Dual Therapy for Effective Respiratory Management

BUDEFLO 200 combines Budesonide I.P. 200 mcg and Formoterol Fumarate Dihydrate I.P. 6 mcg, offering a powerful dual-action approach to manage asthma and chronic obstructive pulmonary disease (COPD). Budesonide, a potent inhaled corticosteroid (ICS), reduces airway inflammation, prevents swelling, and minimizes the risk of exacerbations. Formoterol Fumarate, a long-acting beta-agonist (LABA), ensures rapid and sustained bronchodilation, providing quick relief from breathing difficulties and improving airflow.

The Keyhaler is a state-of-the-art Dry Powder Inhaler (DPI) designed for efficient and effective delivery of respiratory medications. Engineered with precision, the Keyhaler ensures optimal dose consistency with every inhalation, making it ideal for patients with conditions like asthma and COPD.

• Breath-Activated: The device releases the medication when the patient inhales, ensuring ease of use and eliminating the need for hand-breath coordination.
• No Propellant: Utilizing the patient's own inhalation force, the Keyhaler delivers the active ingredients without the need for external propellants, making it environmentally friendly.
• Compact and Portable: With its sleek design, the Keyhaler is easy to carry, making it convenient for everyday use.